PATENT CLAIM ANALYSIS

Application Number: 15906873
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "093210"]

Abstract:
The invention includes compositions and methods related to multimodal therapies, e.g., for treating a cancer. A multimodal therapy described herein provides and/or administers a plurality of agents that function in a coordinated manner to provide a therapeutic benefit to a subject in need thereof, e.g., a subject having a cancer.

Claim (Index 25):
A method of making an enucleated erythroid cell of  claim 1 , comprising:\n providing a nucleated erythroid cell, or a precursor thereof, comprising an exogenous nucleic acid encoding the exogenous fusion polypeptide; and culturing the nucleated erythroid cell, or the precursor thereof, under conditions suitable for enucleation of the nucleated erythroid cell and for production of the exogenous fusion polypeptide, thereby making the enucleated erythroid cell of  claim 1 .

Metadata:
- Claim Count in Document: 65.0
- Percentile: 88.0
- Lexical Diversity: 1.4359
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15716141', '15783921', '15824877', '15473421', '14738414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7467391848340147
- 35 USC 102 Novelty (BERT): 0.5995160325415094
- Combined Prediction Score: 0.7320168696047642
- Mean Citation Score: 392.99089
- Max Citation Score: 539.55566
- Similarity Product: 483.9891855613376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test